Feigelson HS - Search Results

1

Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3).

Ahn J, Schumacher FR, Berndt SI, Pfeiffer R, Albanes D, Andriole GL, Ardanaz E, Boeing H, Bueno-de-Mesquita B, Chanock SJ, Clavel-Chapelon F, Diver WR, Feigelson HS, Gaziano JM, Giovannucci E, Haiman CA, Henderson BE, Hoover RN, Kolonel LN, Kraft P, Ma J, Le Marchand L, Overvad K, Palli D, Stattin P, Stampfer M, Stram DO, Thomas G, Thun MJ, Travis RC, Trichopoulos D, Virtamo J, Weinstein SJ, Yeager M, Kaaks R, Hunter DJ, Hayes RB. Ahn J, et al. Among authors: feigelson hs. Hum Mol Genet. 2009 Oct 1;18(19):3749-57. doi: 10.1093/hmg/ddp302. Epub 2009 Jul 2. Hum Mol Genet. 2009. PMID: 19574343 Free PMC article.

2

Estrogens and breast cancer.

Feigelson HS, Henderson BE. Feigelson HS, et al. Carcinogenesis. 1996 Nov;17(11):2279-84. doi: 10.1093/carcin/17.11.2279. Carcinogenesis. 1996. PMID: 8968038 Review. No abstract available.

3

Genetic susceptibility to cancer from exogenous and endogenous exposures.

Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JK, Henderson BE. Feigelson HS, et al. J Cell Biochem Suppl. 1996;25:15-22. doi: 10.1002/(sici)1097-4644(1996)25+<15::aid-jcb2>3.0.co;2-5. J Cell Biochem Suppl. 1996. PMID: 9027593 Review.

4

A polymorphism in the CYP17 gene increases the risk of breast cancer.

Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE. Feigelson HS, et al. Cancer Res. 1997 Mar 15;57(6):1063-5. Cancer Res. 1997. PMID: 9067272

5

A polymorphism in intron 6 of the CYP17 gene.

Crocitto LE, Feigelson HS, Yu MC, Kolonel LN, Henderson BE, Coetzee GA. Crocitto LE, et al. Among authors: feigelson hs. Clin Genet. 1997 Jul;52(1):68-9. doi: 10.1111/j.1399-0004.1997.tb02519.x. Clin Genet. 1997. PMID: 9272718 No abstract available.

6

Re: Recent trends in U.S. breast cancer incidence, survival, and mortality rates.

Feigelson HS, Henderson BE, Pike MC. Feigelson HS, et al. J Natl Cancer Inst. 1997 Dec 3;89(23):1810-2. doi: 10.1093/jnci/89.23.1810. J Natl Cancer Inst. 1997. PMID: 9392623 No abstract available.

7

Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations.

Feigelson HS, Shames LS, Pike MC, Coetzee GA, Stanczyk FZ, Henderson BE. Feigelson HS, et al. Cancer Res. 1998 Feb 15;58(4):585-7. Cancer Res. 1998. PMID: 9485002 Free article.

8

Sex steroid hormones and genetic susceptibility to breast and prostate cancer.

Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JK, Henderson BE. Feigelson HS, et al. Drug Metab Rev. 1998 May;30(2):421-34. doi: 10.3109/03602539808996320. Drug Metab Rev. 1998. PMID: 9606611 Review. No abstract available.

9

Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility.

Ross RK, Pike MC, Coetzee GA, Reichardt JK, Yu MC, Feigelson H, Stanczyk FZ, Kolonel LN, Henderson BE. Ross RK, et al. Cancer Res. 1998 Oct 15;58(20):4497-504. Cancer Res. 1998. PMID: 9788589 Review.

10

Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapy.

Feigelson HS, McKean-Cowdin R, Pike MC, Coetzee GA, Kolonel LN, Nomura AM, Le Marchand L, Henderson BE. Feigelson HS, et al. Cancer Res. 1999 Aug 15;59(16):3908-10. Cancer Res. 1999. PMID: 10463580

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

172 results

Search Page